Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice

Brain, Behavior, and Immunity

Volumn 26, Issue 6, 2012, Pages 931-941

  Kawanishi, Noriaki ^a,b   Yano, Hiromi ^c   Mizokami, Tsubasa ^a   Takahashi, Masaki ^a   Oyanagi, Eri ^d   Suzuki, Katsuhiko ^a  

^a WASEDA UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c KAWASAKI UNIVERSITY OF MEDICAL WELFARE   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

Chemokine; Exercise training; Fatty liver; Hepatic fibrosis; Hepatic inflammation; Macrophage

Indexed keywords

ALANINE AMINOTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; EXERCISE; HEPATITIS; INNATE IMMUNITY; LIVER FIBROSIS; LIVER INJURY; MALE; METABOLIC SYNDROME X; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; BODY WEIGHT; CHEMOKINE CCL2; DIET, HIGH-FAT; DIETARY FATS; FATTY LIVER; FLOW CYTOMETRY; FRUCTOSE; LIVER CIRRHOSIS; MACROPHAGES; MICE; MICE, INBRED C57BL; OBESITY; ORGAN SIZE; PHYSICAL CONDITIONING, ANIMAL; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863873773     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.04.006     Document Type: Article

References (52)

1. Alkhouri N., Dixon L.J., Feldstein A.E. Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. Expert Rev. Gastroenterol. Hepatol. 2009, 3:445-451.
2. Argo C.K., Northup P.G., Al-Osaimi A.M., Caldwell S.H. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J. Hepatol. 2009, 51:371-379.
3. Baeck C., Wehr A., Karlmark K.R., Heymann F., Vucur M., Gassler N., Huss S., Klussmann S., Eulberg D., Luedde T., Trautwein C., Tacke F. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 2012, 61:416-426.
4. Browning J.D., Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 2004, 114:147-152.
5. Chocian G., Chabowski A., Zendzian-Piotrowska M., Harasim E., Lukaszuk B., Gorski J. High fat diet induces ceramide and sphingomyelin formation in rat's liver nuclei. Mol. Cell. Biochem. 2010, 340:125-131.
6. Dambach D.M., Watson L.M., Gray K.R., Durham S.K., Laskin D.L. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 2002, 35:1093-1103.
7. Day C.P., James O.F. Hepatic steatosis: innocent bystander or guilty party?. Hepatology 1998, 27:1463-1466.
8. Gleeson M., Bishop N.C., Stensel D.J., Lindley M.R., Mastana S.S., Nimmo M.A. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat. Rev. Immunol. 2011, 5:607-615.
9. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
10. Imamura M., Ogawa T., Sasaguri Y., Chayama K., Ueno H. Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 2005, 128:138-146.
11. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006, 116:1494-1505.
12. Karlmark K.R., Weiskirchen R., Zimmermann H.W., Gassler N., Ginhoux F., Weber C., Merad M., Luedde T., Trautwein C., Tacke F. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 2009, 50:261-274.
13. Kawanishi N., Yano H., Yokogawa Y., Suzuki K. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exercise Immunol. Rev. 2010, 16:105-118.
14. Kinoshita M., Uchida T., Sato A., Nakashima M., Nakashima H., Shono S., Habu Y., Miyazaki H., Hiroi S., Seki S. Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. J. Hepatol. 2010, 53:903-910.
15. Kistler K.D., Brunt E.M., Clark J.M., Diehl A.M., Sallis J.F., Schwimmer J.B. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am. J. Gastroenterol. 2010, 106:460-468.
16. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J. Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
17. Kohli R., Kirby M., Xanthakos S.A., Softic S., Feldstein A.E., Saxena V., Tang P.H., Miles L., Miles M.V., Balistreri W.F., Woods S.C., Seeley R.J. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 2010, 52:934-944.
18. Kudo H., Takahara T., Yata Y., Kawai K., Zhang W., Sugiyama T. Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. J. Hepatol. 2009, 51:168-175.
19. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B., Desimone C., Song X.Y., Diehl A.M. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003, 37:343-350.
20. Lim J.S., Mietus-Snyder M., Valente A., Schwarz J.M., Lustig R.H. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol. 2010, 7:251-264.
21. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 2007, 117:175-184.
22. Machado M.V., Ferreira D.M., Castro R.E., Silvestre A.R., Evangelista T., Coutinho J., Carepa F., Costa A., Rodrigues C.M., Cortez-Pinto H. Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. PLoS ONE 2012, 7:e31738.
23. Malhi H., Gores G.J. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin. Liver Dis. 2008, 28:360-369.
24. Marques C.M., Motta V.F., Torres T.S., Aguila M.B., Mandarim-de-Lacerda C.A. Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. Braz. J. Med. Biol. Res. 2010, 43:467-475.
25. Minicis S., Seki E., Paik Y.H., Osterreicher C.H., Kodama Y., Kluwe J., Torozzi L., Miyai K., Benedetti A., Schwabe R.F., Brenner D.A. Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. Hepatology 2010, 52:1420-1430.
26. Miura K., Kodama Y., Inokuchi S., Schnabl B., Aoyama T., Ohnishi H., Olefsky J.M., Brenner D.A., Seki E. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 2010, 139:323-334.
27. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11:723-737.
28. Nara N., Nakayama Y., Okamoto S., Tamura H., Kiyono M., Muraoka M., Tanaka K., Taya C., Shitara H., Ishii R., Yonekawa H., Minokoshi Y., Hara T. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J. Biol. Chem. 2007, 282:30794-30803.
29. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., Otsu M., Hara K., Ueki K., Sugiura S., Yoshimura K., Kadowaki T., Nagai R. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15:914-920.
30. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., Red Eagle A., Vats D., Brombacher F., Ferrante A.W., Chawla A. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120.
31. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
32. Pedersen B.K. Exercise-induced myokines and their role in chronic diseases. Brain Behav. Immun. 2011, 25:811-816.
33. Pedersen B.K., Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand. J. Med. Sci. Sports 2006, 16:3-63.
34. Popov Y., Schuppan D. CD8+ T cells drive adipose tissue inflammation-a novel clue for NASH pathogenesis?. J. Hepatol. 2010, 52:130-132.
35. Promrat K., Kleiner D.E., Niemeier H.M., Jackvony E., Kearns M., Wands J.R., Fava J.L., Wing R.R. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010, 51:121-129.
36. Röckl K.S., Hirshman M.F., Brandauer J., Fujii N., Witters L.A., Goodyear L.J. Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift. Diabetes 2007, 56:2062-2069.
37. Roth, C.L., Elfers, C.T., Figlewicz, D.P., Melhorn, S.J., Morton, G.J., Hoofnagle, A., Yeh, M.M., Nelson, J.E., Kowdley, K.V., 2011. Vitamin D deficiency in obese rats exacerbates NAFLD and increases hepatic resist in and toll-like receptor activation. Hepatology [Epub. ahead of print].
38. Schultz, A., Mendonca, L.S., Aguila, M.B., Mandarim-de-Lacerda, C.A., 2010. Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease. Exp. Toxicol. Pathol. [Epub. ahead of print].
39. Seki E., De Minicis S., Inokuchi S., Taura K., Miyai K., van Rooijen N., Schwabe R., Brenner D.A. CCR2 promotes hepatic fibrosis in mice. Hepatology 2009, 50:185-197.
40. Seki E., De Minicis S., Osterreicher C.H., Kluwe J., Osawa Y., Brenner D.A., Schwabe R.F. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 2007, 13:1324-1332.
41. Sohet F.M., Neyrinck A.M., Pachikian B.D., de Backer F.C., Bindels L.B., Niklowitz P., Menke T., Cani P.D., Delzenne N.M. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem. Pharmacol. 2009, 78:1391-1400.
42. Sreenivasa Baba.C., Alexander G., Kalyani B., Pandey R., Rastogi S., Pandey A., Choudhuri G. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J. Gastroenterol. Hepatol. 2006, 21:191-198.
43. Szabo G., Dolganiuc A., Mandrekar P. Pattern recognition receptors: a contemporary view on liver diseases. Hepatology 2006, 44:287-298.
44. Tamura Y., Sugimoto M., Murayama T., Minami M., Nishikaze Y., Ariyasu H., Akamizu T., Kita T., Yokode M., Arai H. C-C chemokine receptor 2 inhibitor improves diet-induced development of insulin resistance and hepatic steatosis in mice. J. Atheroscler. Thromb. 2010, 31:219-228.
45. Tetri L.H., Basaranoglu M., Brunt E.M., Yerian L.M., Neuschwander-Tetri B.A. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G987-G995.
46. + regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. U S A 2007, 104:19446-19451.
47. Tomita K., Tamiya G., Ando S., Ohsumi K., Chiyo T., Mizutani A., Kitamura N., Toda K., Kaneko T., Horie Y., Han J.Y., Kato S., Shimoda M., Oike Y., Tomizawa M., Makino S., Ohkura T., Saito H., Kumagai N., Nagata H., Ishii H., Hibi T. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 2006, 55:415-424.
48. Vieira V.J., Valentine R.J., Wilund K.R., Antao N., Baynard T., Woods J.A. Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E1164-E1171.
49. Wang J., Leclercq I., Brymora J.M., Xu N., Ramezani-Moghadam M., London R.M., Brigstock D., George J. Kupffer cells mediate leptin-induced liver fibrosis. Gastroenterology 2009, 137:713-723.
50. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., Dorfman R., Wang Y., Zielenski J., Mastronardi F., Maezawa Y., Drucker D.J., Engleman E., Winer D., Dosch H.M. Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 2009, 15:921-929.
51. Zhan Y.T., An W. Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J. Gastroenterol. 2010, 16:4652-4660.
52. Zhang W., Kudo H., Kawai K., Fujisaka S., Usui I., Sugiyama T., Tsukada K., Chen N., Takahara T. Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease. Biochem. Biophys. Res. Commun. 2010, 391:1731-1736.